AIE fluorescent probe, preparation method and application thereof, and AIE fluorescent probe kit
By designing AIE fluorescent probes to utilize the cleavage characteristics of virus 3C protein, combined with tetraphenylethylene and polypeptide, the rapid detection of foot-and-mouth disease virus is achieved, and the problem of cumbersome and long-term detection steps in the existing technology is solved, providing an efficient and simple Detection method.
Patent Information
- Application Number
- CN202411172306.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-12-03
AI Technical Summary
The existing foot-and-mouth disease virus detection methods are cumbersome, requiring more reagents and advanced equipment, and the detection time is long, which cannot meet the needs of rapid testing.
An AIE fluorescent probe was designed, using the binding of tetraphenylethylene and Thr-Glu-Ser-Gly polypeptides to achieve aggregation-induced luminescence through the cleavage of virus 3C protein. It is used to quickly detect foot-and-mouth disease viruses and provide AIE fluorescent probes. The kit is subjected to one-step enzymatic reaction detection.
The rapid detection of foot-and-mouth disease virus is achieved, which reduces the detection steps and time, simplifies sample requirements, does not require antibodies or complement, and the detection time is shortened to 1 day.
Smart Images

Figure CN119060125A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of virus detection, and specifically relates to an AIE fluorescent probe and a preparation method and application thereof, and an AIE fluorescent probe kit. Background Art
[0002] Currently, there are two main methods for laboratory diagnosis of foot-and-mouth disease, one is serological diagnosis and the other is ELISA diagnostic kit.
[0003] The principle of serological diagnosis: using the ability of the virus to agglutinate animal red blood cells; using the specific neutralizing effect of serum neutralizing antibodies on the virus to make the virus lose its infectivity to susceptible animals and sensitive cells; complement is involved in both the antigen-antibody system and the hemolytic system reaction, using the hemolytic system as an indicator, and limited complement to determine the viral antigen; coupling the foot-and-mouth disease virus (FMDV) antibody to the aldehyde-desensitized sheep red blood cells, the antibody is adsorbed on the red blood cell surface and combines with the free antigen to form an antigen-antibody agglutination network, and the sheep red blood cells agglutinate together, showing a red blood cell agglutination phenomenon visible to the naked eye.
[0004] Principle of ELISA diagnostic kit: A fixed amount of virus antigen pre-titrated reacts with the serum to be tested, and then the antigen-antibody complex is transferred to the ELISA plate coated with FMDV-specific antibodies, followed by the addition of detection antibodies, enzyme conjugates, colorimetric substrates and reaction stop solutions, and finally the results are read with an ELISA reader. If the serum to be tested contains a certain type of antibody, it must bind to the same type of virus antigen. Finally, the result is determined by comparing the color of the test well with the color of the antigen control well (without serum).
[0005] The above medical biological methods have complicated detection steps and require more reagents, such as antibodies and animal red blood cells. They are qualitatively determined by detecting complement and reading with an enzyme marker, which places high demands on experimental conditions and equipment. In addition, the test results of serological tests take at least 2 to 3 days; ELISA diagnostic kit tests usually take about 2 days. Summary of the invention
[0006] In view of this, the object of the present invention is to provide an AIE fluorescent probe and a preparation method and application thereof, and an AIE fluorescent probe kit. The AIE fluorescent probe and AIE fluorescent probe kit provided by the present invention can realize rapid detection of foot-and-mouth disease virus with simple steps.
[0007] In order to achieve the above object, the present invention provides the following scheme:
[0008] The present invention provides an AIE fluorescent probe having a structure shown in Formula I:
[0009]
[0010] The present invention provides a method for preparing the AIE fluorescent probe described in the above scheme, comprising the following steps:
[0011] The dissolving solution of formaldehyde tetraphenylethylene, the dissolving solution of TESG polypeptide, the solution of cosolvent and the solution of catalyst are mixed, and a dehydration condensation reaction is performed to obtain the AIE fluorescent probe; the sequence of the TESG polypeptide is shown in SEQ ID NO.1, which is Thr-Glu-Ser-Gly;
[0012] The formaldehyde tetraphenylethylene has a structure shown in Formula II:
[0013]
[0014] Preferably, the temperature of the dehydration condensation reaction is 3-6°C and the time is 8-12 hours.
[0015] Preferably, the mass ratio of the formaldehyde tetraphenylethylene to the TESG polypeptide is (0.5-1.5):1.
[0016] Preferably, the mixing comprises:
[0017] The dissolving solution of formaldehyde tetraphenylethylene and the dissolving solution of TESG polypeptide are mixed, and then the solution of co-solvent and catalyst are added.
[0018] Preferably, the co-solvent comprises triethylamine-ethanol solution.
[0019] Preferably, the catalyst comprises sodium borohydride; and the mass ratio of the TESG polypeptide to the catalyst is 1:(0.5-1.5).
[0020] The present invention provides the use of the AIE fluorescent probe described in the above scheme or the AIE fluorescent probe prepared by the preparation method described in the above scheme in detecting foot-and-mouth disease virus for non-disease diagnosis and treatment purposes.
[0021] The present invention provides an AIE fluorescent probe kit, comprising an AIE fluorescent probe and a PBS buffer solution; the AIE fluorescent probe is the AIE fluorescent probe described in the above scheme or the AIE fluorescent probe prepared by the preparation method described in the above scheme.
[0022] Preferably, the concentration of the PBS buffer solution is 0.03-0.05 mol / L, and the pH value is 7.2-7.6.
[0023] The present invention provides an AIE fluorescent probe having a structure shown in Formula I:
[0024]
[0025] In the present invention, AIE refers to aggregation-induced emission, and its full English name is Aggregation-induced Emission.
[0026] The AIE fluorescent probe (TPE-TESG for short) provided by the present invention comprises a hydrophobic AIE-based fluorophore and a hydrophilic TESG peptide sequence; the hydrophobic AIE-based fluorophore is composed of tetraphenylethylene; the AIE fluorescent probe provided by the present invention is completely soluble in water and does not emit fluorescence in an aqueous medium. Because the tetrapeptide Thr-Glu-Ser-Gly (TESG) is the key amino acid sequence of the natural substrate 3B3-3C of the FMDV virus 3C protease, the 3C protein can recognize and cut between Glu-Ser (i.e., TPE-TESG is hydrolyzed to generate TPE-TE and SG). After cutting, the hydrophobic TPE residue part (TPE-TE) aggregates due to decreased water solubility, and then releases the fluorescence of TPE due to limited intramolecular motion, thereby realizing rapid detection of foot-and-mouth disease virus.
[0027] The present invention utilizes the aggregation-induced emission (AIE) property of tetraphenylethylene (TPE) and the ability of the 3C protein of the foot-and-mouth disease virus FMDV to cleave itself, and designs and synthesizes the TPE-TESG peptide probe for FMDV. The foot-and-mouth disease virus FMDV belongs to the Picornaviridae family. Picornaviridae contain an open reading frame that instructs the virus to utilize the host protein synthesis system to transcode a large polyprotein, and then hydrolyzes the protein precursor into multiple functional proteins through cleavage by its own protease. The present invention utilizes the property of one of the hydrolases, the 3C protein, to cleave the specific amino acid sequence of the virus's own substrate, and connects this small peptide to the TPE (tetraphenylethylene) fluorescent molecule to design a TPE-TESG peptide fluorescent probe that can be used for the detection of FMDV.
[0028] The present invention combines the 3C protein hydrolysis peptide segment process of the virus with fluorescence detection to detect whether the foot-and-mouth disease virus is infected, providing a new method and new idea for the determination of the foot-and-mouth disease virus.
[0029] The present invention provides an AIE fluorescent probe kit, comprising an AIE fluorescent probe and a PBS buffer solution; the AIE fluorescent probe is the AIE fluorescent probe described in the above scheme or the AIE fluorescent probe prepared by the preparation method described in the above scheme. The AIE fluorescent probe and the AIE fluorescent probe kit provided by the present invention are used to detect foot-and-mouth disease virus FMDV, and the virus is detected by a one-step enzymatic reaction, which is efficient and simple; the requirements for the detection sample are reduced, and antibodies, complement, etc. are not required in the sample for detection. The AIE fluorescent probe and the AIE fluorescent probe kit provided by the present invention can realize the rapid detection of foot-and-mouth disease virus, and the detection time is 1 day. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative labor.
[0031] Figure 1 This is a test result diagram of Application Example 1 of the present invention;
[0032] Figure 2 The AIE fluorescent probe of the present invention is 1 H-NMR spectrum;
[0033] Figure 3 The AIE fluorescent probe of the present invention is 13 C-NMR spectrum. DETAILED DESCRIPTION
[0034] The present invention provides an AIE fluorescent probe having a structure shown in Formula I:
[0035]
[0036] The AIE fluorescent probe (TPE-TESG for short) provided by the present invention comprises a hydrophobic AIE-based fluorophore and a hydrophilic TESG peptide sequence; the hydrophobic AIE-based fluorophore is composed of tetraphenylethylene; the AIE fluorescent probe provided by the present invention is completely soluble in water and does not emit fluorescence in an aqueous medium. Because the tetrapeptide Thr-Glu-Ser-Gly (TESG) is the key amino acid sequence of the natural substrate 3B3-3C of the FMDV virus 3C protease, the 3C protein can recognize and cut between Glu-Ser (i.e., TPE-TESG is hydrolyzed to generate TPE-TE and SG). After cutting, the hydrophobic TPE residue part (TPE-TE) aggregates due to decreased water solubility, and then releases the fluorescence of TPE due to limited intramolecular motion, thereby realizing rapid detection of foot-and-mouth disease virus.
[0037] The present invention provides a method for preparing the AIE fluorescent probe described in the above scheme, comprising the following steps:
[0038] The dissolving solution of formaldehyde tetraphenylethylene, the dissolving solution of TESG polypeptide, the solution of cosolvent and the solution of catalyst are mixed, and a dehydration condensation reaction is performed to obtain the AIE fluorescent probe; the sequence of the TESG polypeptide is shown in SEQ ID NO.1, which is Thr-Glu-Ser-Gly;
[0039] The formaldehyde tetraphenylethylene has a structure shown in Formula II:
[0040]
[0041] In the present invention, the mixing preferably comprises: mixing a solution of formaldehyde tetraphenylethylene and a solution of TESG polypeptide, and then adding a solution of a co-solvent and a catalyst.
[0042] In the present invention, the dissolving solution of formaldehyde tetraphenylethylene is preferably obtained by dissolving formaldehyde tetraphenylethylene in an alcohol solvent. In the present invention, the alcohol solvent preferably includes ethanol; and the concentration of the dissolving solution of formaldehyde tetraphenylethylene is preferably 2-3 mg / mL.
[0043] In the present invention, the TESG polypeptide solution is preferably obtained by dissolving the TESG polypeptide in an alcohol-water solvent. In the present invention, the alcohol-water solvent preferably includes an ethanol-water solvent; the concentration of the TESG polypeptide solution is preferably 3-4 mg / mL; the volume ratio of alcohol to water in the alcohol-water solvent is preferably 1:1.
[0044] In the present invention, before preparing the TESG polypeptide solution, the method preferably further comprises freeze-drying the TESG polypeptide.
[0045] In the present invention, the cosolvent preferably includes a triethylamine-ethanol solution; the volume ratio of triethylamine to ethanol in the triethylamine-ethanol solution is preferably 1:1; the mass of the TESG polypeptide and the volume ratio of the cosolvent are preferably 10 mg:1 mL.
[0046] After adding the co-solvent, the present invention preferably stirs the resulting solution; the stirring temperature is preferably 4° C., and the stirring time is preferably 30 min.
[0047] In the present invention, the co-solvent can adjust the polarity of the solvent in the reaction system, increase the solubility of the reactants, and facilitate the subsequent dehydration condensation reaction.
[0048] In the present invention, the catalyst preferably includes sodium borohydride; the mass ratio of the TESG polypeptide to the catalyst is preferably 1:(0.5-1.5), and more preferably 1:(0.8-1.2); the solution concentration of the catalyst is preferably 15-20 mg / mL, and more preferably 16-19 mg / mL.
[0049] In the present invention, the mass ratio of the formaldehyde tetraphenylethylene to the TESG polypeptide is preferably (0.5-1.5):1, and more preferably (0.8-1.2):1.
[0050] In the present invention, the temperature of the dehydration condensation reaction is preferably 3 to 6° C., more preferably 4° C., and the time is 8 to 12 h, more preferably 9 to 10 h.
[0051] After the dehydration condensation reaction is completed, the present invention preferably centrifuges the obtained reaction solution and separates it to obtain a supernatant; then, acetone is added to the obtained supernatant to precipitate the sample, and then the precipitate is separated by centrifugation and dried to obtain the AIE fluorescent probe.
[0052] In the present invention, the synthesis route of the AIE fluorescent probe is shown in formula a:
[0053]
[0054] The present invention utilizes the aggregation-induced emission (AIE) property of tetraphenylethylene (TPE) and the ability of the 3C protein of the foot-and-mouth disease virus FMDV to cleave itself, and designs and synthesizes the TPE-TESG peptide probe for FMDV. The foot-and-mouth disease virus FMDV belongs to the Picornaviridae family. Picornaviridae contain an open reading frame that instructs the virus to utilize the host protein synthesis system to transcode a large polyprotein, and then hydrolyzes the protein precursor into multiple functional proteins through cleavage by its own protease. The present invention utilizes the property of one of the hydrolases, the 3C protein, to cleave the specific amino acid sequence of the virus's own substrate, and connects this small peptide to the TPE (tetraphenylethylene) fluorescent molecule to design a TPE-TESG peptide fluorescent probe that can be used for the detection of FMDV.
[0055] The present invention combines the 3C protein hydrolysis peptide segment process of the virus with fluorescence detection to detect whether the foot-and-mouth disease virus is infected, providing a new method and new idea for the determination of the foot-and-mouth disease virus.
[0056] The present invention provides the use of the AIE fluorescent probe described in the above scheme or the AIE fluorescent probe prepared by the preparation method described in the above scheme in detecting foot-and-mouth disease virus for non-disease diagnosis and treatment purposes.
[0057] The present invention provides an AIE fluorescent probe kit, comprising an AIE fluorescent probe and a PBS buffer solution; the AIE fluorescent probe is the AIE fluorescent probe described in the above scheme or the AIE fluorescent probe prepared by the preparation method described in the above scheme.
[0058] In the present invention, the concentration of the PBS buffer solution is preferably 0.03-0.05 mol / L, more preferably 0.04 mol / L, and the pH value is preferably 7.2-7.6, more preferably 7.4.
[0059] The present invention provides a method for using the AIE fluorescent probe kit described in the above scheme, comprising the following steps: mixing the AIE fluorescent probe, PBS buffer solution and the biological sample to be tested, and co-incubating them.
[0060] In the present invention, the biological sample to be tested preferably includes a cell culture fluid infected with a virus, secretions of a diseased animal, exudate from damaged tissue or a serum sample; in the present invention, the volume ratio of the PBS buffer solution to the volume of the biological sample to be tested is preferably 1:1; the concentration of the AIE fluorescent probe in the PBS buffer solution is preferably 40 to 80 μmol / L, more preferably 50 to 70 μmol / L, and more preferably 55 to 65 μmol / L. In the present invention, the co-incubation temperature is preferably 37°C, and the time is preferably 2 to 3 hours.
[0061] After the co-incubation is completed, the present invention observes the co-incubated solution in the dark. If blue fluorescence is observed, it indicates the presence of foot-and-mouth disease virus; if there is no blue fluorescence, there is no foot-and-mouth disease virus.
[0062] The AIE fluorescent probe and AIE fluorescent probe kit provided by the present invention are used to detect foot-and-mouth disease virus FMDV. The virus is detected by a one-step enzymatic reaction, which is efficient and simple; the requirements for the detection sample are reduced, and antibodies, complement, etc. are not required in the sample for detection. The AIE fluorescent probe provided by the present invention can realize the rapid detection of foot-and-mouth disease virus, and the detection time is 1 day.
[0063] In order to further illustrate the present invention, an AIE fluorescent probe and its preparation method and application, and an AIE fluorescent probe kit provided by the present invention are described in detail below in combination with the accompanying drawings and examples, but they should not be understood as limiting the scope of protection of the present invention.
[0064] In the embodiments of the present invention, TPE-CHO (purity>95%) was purchased from Delta Bioreagent Company, catalog number (Q-0001471). The peptide Thr-Glu-Ser-Gly (purity>95%) was commissioned to be synthesized by Hangzhou Zhongpeptide Biochemical Co., Ltd. Ethanol (analytical grade) and sodium borohydride (analytical grade) were purchased from Sinopharm Chemical Reagent Co., Ltd., and triethylamine (analytical grade) was purchased from Aladdin Biochemical Technology Co., Ltd.
[0065] Example 1
[0066] Probe synthesis: TPE is covalently bound to the N-terminus of the TESG peptide. Weigh 6.4 mg of TPE-CHO powder and place it in a centrifuge tube, add 3 mL of ethanol solution to dissolve it; weigh 10 mg of polypeptide (Thr-Glu-Ser-Gly) lyophilized powder and place it in another centrifuge tube, add 3 mL of ethanol-water (1:1, v / v) mixed solution to dissolve it; then transfer the TPE-CHO solution and polypeptide solution to a glass bottle, shake and mix, add 1 mL of triethylamine-ethanol solution (1:1, v / v) to the glass bottle after mixing, and place it at 4°C, stir it with a magnetic stirrer for 30 minutes, and then add 0.5 mL of sodium borohydride solution (18.5 mg / mL) to react overnight at 4°C for 12 hours; then centrifuge the obtained product solution for 5 minutes and separate it to obtain a yellow supernatant, add acetone to the obtained yellow supernatant to precipitate the sample, and finally obtain the purified product AIE fluorescent probe, namely TPE-TESG, by centrifugation, precipitation, and drying.
[0067] Figure 2 The AIE fluorescent probe of the present invention is 1 H-NMR spectrum; Figure 3 The AIE fluorescent probe of the present invention is 13 C-NMR graph. Experimental instrument: INOVA-400 and Bruker-400 superconducting nuclear magnetic resonance spectrometers were used. TMS was used as the internal standard, chemical shift values were expressed as δ, single peaks were expressed as s, doublets were expressed as d, triplet peaks were expressed as t, multiple peak signals were expressed as m, overlapping signals were expressed as o, and the unit of coupling constants was Hz. The hydrogen spectrum data were shown in Table 1, and the carbon spectrum data were shown in Table 2.
[0068] Table 1 TPE-TESG 1 H data (in CD3OD)
[0069]
[0070]
[0071] Table 2 TPE-TESG 13 C-NMR data (in CD3OD)
[0072] Location Chemical shift a 174~178 b 126-136 c 68.4 d 69.1 e 64.8 f 58.6 g 55.1 h 52.1 i Overlapping solvent peak j 29.7 k 26.9 l 17.3
[0073] Note: The position of C in Table 2 is shown in Formula III:
[0074]
[0075] According to the above data and spectrum analysis, the obtained product is the target product TPE-TESG.
[0076] Application Example 1
[0077] The blister fluid of a typical clinically ill pig was collected, and 1000 IU / mL of penicillin and 500 IU / mL of streptomycin were added. The fluid was aspirated with a sterile syringe and placed into a sample preservation tube, which was sealed with a cap and stored in a freezer.
[0078] Take another test tube as a negative control: add purified water, 1000 IU / mL of penicillin and 500 IU / mL of streptomycin, and seal it with a cap.
[0079] Weigh 0.4 mg of TPE-TESG, dissolve it in 0.04 mol / L, pH=7.4 phosphate buffered saline (PBS solution) and dilute to 5 mL, add 5 mL of the collected sample blister solution, incubate in a 37°C water bath for 2 h, and observe fluorescence (blue fluorescence in the dark). Figure 1 .
[0080] TPE-TESG weighed in the same way was made up to 5 mL with PBS, 5 mL of negative control solution was added, and the mixture was incubated in a 37°C water bath for 2 h to observe if there was no fluorescence.
[0081] Although the above embodiment describes the present invention in detail, it is only a part of the embodiments of the present invention, not all of the embodiments. People can also obtain other embodiments based on this embodiment without creativity, and these embodiments all fall within the protection scope of the present invention.
Claims
1. An AIE fluorescent probe having a structure shown in Formula I:
2. The method for preparing the AIE fluorescent probe according to claim 1, The following steps are involved: The dissolving solution of formaldehyde tetraphenylethylene, the dissolving solution of TESG polypeptide, the solution of cosolvent and the solution of catalyst are mixed, and a dehydration condensation reaction is performed to obtain the AIE fluorescent probe; the sequence of the TESG polypeptide is shown in SEQ ID NO.1, which is Thr-Glu-Ser-Gly; The formaldehyde tetraphenylethylene has a structure shown in Formula II:
3. The preparation method according to claim 2, It is characterized in that The temperature of the dehydration condensation reaction is 3-6°C and the time is 8-12 hours.
4. The preparation method according to claim 2 or 3, It is characterized in that The mass ratio of the formaldehyde tetraphenylethylene and the TESG polypeptide is (0.5-1.5):
1.
5. The preparation method according to claim 2, It is characterized in that The mixing includes: The dissolving solution of formaldehyde tetraphenylethylene and the dissolving solution of TESG polypeptide are mixed, and then the solution of co-solvent and catalyst are added.
6. The preparation method according to claim 2 or 5, It is characterized in that The co-solvent includes triethylamine-ethanol solution.
7. The preparation method according to claim 2 or 5, It is characterized in that The catalyst includes sodium borohydride; the mass ratio of the TESG polypeptide to the catalyst is 1:(0.5-1.5).
8. Use of the AIE fluorescent probe according to claim 1 or the AIE fluorescent probe prepared by the preparation method according to any one of claims 2 to 7 in detecting foot-and-mouth disease virus for purposes other than disease diagnosis and treatment.
9. An AIE fluorescent probe kit, comprising an AIE fluorescent probe and a PBS buffer solution; the AIE fluorescent probe is the AIE fluorescent probe according to claim 1 or the AIE fluorescent probe prepared by the preparation method according to any one of claims 2 to 7.
10. The AIE fluorescent probe kit according to claim 9, It is characterized in that The concentration of the PBS buffer solution is 0.03-0.05 mol / L, and the pH value is 7.2-7.6.
